[Ip-health] WSJ: CVS Gives Preferred Status to Gilead¹s Hepatitis C Drugs

George Carter fiar at verizon.net
Thu Jan 8 05:56:12 PST 2015

On Jan 8, 2015, at 8:37 AM, Baker, Brook wrote:

> Companies also do it on the basis of stringent secrecy so that they can
> continue to extort higher prices from smaller insurers and consumers.  The
> lack of transparency between Gilead's new price and AbbVie's also means
> that analysts and advocates will not be able to measure the level and
> conditionalities of price discounts and there are reduced opportunities
> for additional price pressure and open competition between the drug
> company oligopolies.

Why Professor Baker, I DO believe what you've described here is the criminal act of PRICE FIXING. A somewhat informal form of it but just the same--and accompanied by hefty doses of extortion.

Profit>Life = Economic Genocide.
George M. Carter

More information about the Ip-health mailing list